What are our options for children with severe asthma?
This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice.
The appropriate use of inhaled corticosteroids (ICS) in COPD
This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice.
Prescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities
This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.
High cost drugs in psoriasis: how to optimise patient care and budgets
This supplement has been commissioned and funded by Almirall Ltd and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals only.
UK-NOP-2000055
Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust
This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D
An optimised patient pathway for the treatment of heterosexual patients with infertility
This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.
Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic
This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
Identification and management of patients with malnutrition
This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.
Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities
This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.
How should inhaled steroids be used in the management of asthma in adults within a primary care setting?
Information intended for healthcare professionals only.
Managing common skin conditions without antibiotics
This supplement has been commissioned and funded by Galderma and developed in partnership with Guidelines in Practice.
Guideline for the managed introduction of biosimilar basal insulin
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.
Cost-benefit of prescribing emollients for eczema patients
The content of this infographic has been developed by Johnson & Johnson Ltd.
NICE guidance on respiratory conditions and COVID-19: 5-minute video
Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context
Death certification in COVID-19: 5-minute video
Dr Toni Hazell highlights important things you need to know about changes to death certification processes during the COVID-19 outbreak
Secondary event prevention and risk stratification in patients with symptomatic peripheral arterial disease (PAD)
The development of this Guidelines in Practice video has been commissioned by Bayer plc.
Secondary event prevention and risk stratification in patients with stable coronary artery disease (CAD)
The development of this Guidelines in Practice video has been commissioned by Bayer plc.
Implementing the Guidelines algorithm on identifying and managing allergic rhinitis in the asthma population
Information intended for healthcare professionals only.
Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for acne vulgaris
Information intended for healthcare professionals only.
Implementing the clinical guideline on pancreatic exocrine insufficiency in diabetes
Information intended for healthcare professionals only.
Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for actinic (solar) keratosis
Information intended for healthcare professionals only.
Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities
This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited.
Case study on Type 2 diabetes management: implementation of a DPP-4 inhibitor switch strategy across a primary care network
This advertorial has been commissioned and developed by Takeda UK Ltd.